Login / Signup

Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies.

Zhuoer XieAntoine N SalibaJithma AbeykoonUmair MajeedDaniel R AlmquistJulia E WiedmeierEvandro BezerraXavier Andrade-GonzalezAshley HickmanKarl SorensonSagar RakshitChristopher E WeeSri Harsha TellaAnuhya KommalapatiNadine AbdallahJoshua C PritchettMariza De AndradeDipesh UpretyAndrew BadleyRami ManochakianSikandar AilawadhiAlan H BryceJoleen M HubbardNaseema GangatCarrie A ThompsonThomas E WitzigRobert R McWilliamsKonstantinos LeventakosThorvardur R Halfdanarson
Published in: JCO oncology practice (2021)
The COVID-19 positivity rate was low on the basis of RS. Comparing the hospital admission and mortality outcomes with the NRS cohort, there were no significant differences. The value of routine pre-emptive screening of asymptomatic patients with cancer for COVID-19 remains low.
Keyphrases
  • coronavirus disease
  • sars cov
  • emergency department
  • respiratory syndrome coronavirus
  • healthcare
  • type diabetes
  • cardiovascular events
  • skeletal muscle
  • glycemic control
  • weight loss